Yanqi Dang
Biographic Data
| ID | 7262743 |
|---|---|
| NAME | Yanqi Dang |
| GIVEN NAMES | Yanqi |
| FAMILY NAME | Dang |
| SIGNATURE | DANG Y |
| AFFILIATIONS | Shanghai University of Traditional Chinese Medicine |
| ORCID | 0000-0002-0316-7880 |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Epidemic trends and characteristics of notifiable infectious diseases in mainland China during the Covid-19
Background: The implementation of COVID-19 control and prevention measures has significantly influenced the incidence rates of multiple notifiable infectious diseases. We aimed to investigate the epidemiological trends of notifiable infectious diseases in mainland China from 2020 to 2024, a period spanning both stringent interventions and their subsequent relaxation. Methods: We systematically analysed surveillance data from the National Center f…
Ling-Gui-Zhu-Gan decoction improves hepatic steatosis through ALKBH1-mediated DNA N6-methyladenosine modification
Gan-Jiang-Ling-Zhu decoction improves steatohepatitis induced by choline-deficient-high-fat-diet through the METTL14/N6-methyladenosine-mediated Ugt2a3 expression
GJLZ decoction demonstrates potential in alleviating CDHFD-induced NASH by modulating the METTL14-m 6 A-Ugt2a3 axis, offering a novel therapeutic approach for NASH treatment
Targeted metabolomics revealed the mechanisms underlying the role of Liansu capsule in ameliorating functional dyspepsia
Our findings indicated that Liansu capsule improved FD by regulating the deoxycholic acid/hyodeoxycholic acid-TGR5-STAT3-KLF5 axis. The findings reveal a novel mechanism underlying the role of Liansu capsule, which may be a promising therapeutic strategy for FD
Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice
No prominent works on this page.
Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice
Targeted metabolomics revealed the mechanisms underlying the role of Liansu capsule in ameliorating functional dyspepsia
Our findings indicated that Liansu capsule improved FD by regulating the deoxycholic acid/hyodeoxycholic acid-TGR5-STAT3-KLF5 axis. The findings reveal a novel mechanism underlying the role of Liansu capsule, which may be a promising therapeutic strategy for FD
Gan-Jiang-Ling-Zhu decoction improves steatohepatitis induced by choline-deficient-high-fat-diet through the METTL14/N6-methyladenosine-mediated Ugt2a3 expression
GJLZ decoction demonstrates potential in alleviating CDHFD-induced NASH by modulating the METTL14-m 6 A-Ugt2a3 axis, offering a novel therapeutic approach for NASH treatment
Epidemic trends and characteristics of notifiable infectious diseases in mainland China during the Covid-19
Background: The implementation of COVID-19 control and prevention measures has significantly influenced the incidence rates of multiple notifiable infectious diseases. We aimed to investigate the epidemiological trends of notifiable infectious diseases in mainland China from 2020 to 2024, a period spanning both stringent interventions and their subsequent relaxation. Methods: We systematically analysed surveillance data from the National Center f…
Ling-Gui-Zhu-Gan decoction improves hepatic steatosis through ALKBH1-mediated DNA N6-methyladenosine modification
Biochemistry (3 works) · Biology (3 works) · Fatty liver (3 works) · Internal Medicine (3 works) · Liver Disease Diagnosis and Treatment (3 works) · Medicine (3 works) · Bile acid (2 works) · Decoction (2 works) · Endocrinology (2 works) · Gut microbiota and health (2 works)